Kiniksa completes redomiciliation from Bermuda to UK, shares trade on Nasdaq under same symbol KNSA

Kiniksa Pharmaceuticals International, plc

Effective June 27, 2024, Kiniksa redomiciled to UK via Bermuda court-approved scheme of arrangement.
Shareholders received one-for-one exchange of shares; ~40.4M Class A, 1.8M B, 12.8M A1, 16.1M B1 ordinary shares issued.
Class A Ordinary Shares continue trading on Nasdaq under symbol KNSA as of June 28, 2024.
Same executive officers and directors continue; indemnification agreements and equity plans assumed.
Depositary receipts issued for shares not directly eligible for DTC transfer to avoid UK stamp duty.

item 1.01 item 3.01 item 3.02 item 3.03 item 5.03 item 5.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.